SECsense Logo

Cyclo Therapeutics, Inc. 8-K Filing Report: Key Insights from January 3, 2025

$CYTH
Form 8-K
Filed on: 2025-01-03
Source
Cyclo Therapeutics, Inc. 8-K Filing Report: Key Insights from January 3, 2025

Based on the provided XML section of the financial report, here are the key insights and information extracted:

  1. Entity Identification:
  • Company Name: Cyclo Therapeutics, Inc.
  • CIK (Central Index Key): 0000922247
  • State of Incorporation: Nevada (NV)
  • Industry Code: 6714 (likely related to the biopharmaceutical sector)
  1. Report Type and Date:
  • Filing Type: 8-K (current report used to disclose important events that shareholders should know about)
  • Filing Date: January 3, 2025
  1. Location:
  • Address: 6714 NW 16th Street, Suite B, Gainesville, FL 32653
  • Phone Number: 386-418-8060
  1. Securities Information:
  • Common Stock Ticker: CYTH (traded on NASDAQ)
  • Warrants to Purchase Common Stock Ticker: CYTHW (traded on NASDAQ)
  1. Stock Classifications:
  • The report references two classes of stock:
    • Common Stock (identified as ctdh:CommonStockCustomMember)
    • Warrants to Purchase Common Stock (identified as ctdh:WarrantsToPurchaseCommonStockCustomMember)
  1. Reporting Period:
  • The reporting period for the financial data is for a single day, January 3, 2025, which suggests that this filing may pertain to a specific event or transaction occurring on that date.
  1. Financial Namespace:
  • The report utilizes the US GAAP (Generally Accepted Accounting Principles) and is compliant with XBRL (eXtensible Business Reporting Language) standards, indicating structured financial reporting.

Conclusion: This filing appears to be a significant disclosure from Cyclo Therapeutics, Inc., indicating either a corporate event, financial transaction, or regulatory compliance. The focus on both common stock and warrants may point towards capital raising activities or changes in equity structure. Investors and stakeholders should monitor this filing for potential implications on the company's financial health and market position.